Article
Novel Oral-edaravone Attenuates Diastolic Dysfunction of Diabetic Cardiomyopathy via Activating the Nrf2 Signaling Pathway
2021-09-28
Abstract excerpt
<title>Abstract</title> <p>Background Diastolic dysfunction is the most common change of diabetic cardiomyopathy (DCM), but there is no effective clinical treatment at present. Oxidative stress plays a crucial role in the pathophysiological process of diabetic diastolic dysfunction including hypertrophy, apoptosis and fibrosis. The novel Oral-edaravone (OED) alleviates oxidative stress by scavenging free radical...
Topics
Open a Topic to create a Post that cites this publication.
- Adipose Tissue and Metabolism
- Cardiovascular Function and Risk Factors
- Cardiovascular, Neuropeptides, and Oxidative Stress Research
- FOXO transcription factor regulation
- Genomics, phytochemicals, and oxidative stress
- Metabolism, Diabetes, and Cancer
- Pancreatic function and diabetes
- Parkinson's Disease Mechanisms and Treatments
Identifiers and source
- Literature Corpus work
- 5e118d70-9e89-5306-b3ec-b8ac9301e199
- DOI
- 10.21203/rs.3.rs-936670/v1
